Strs Ohio Agenus Inc Transaction History

Strs Ohio

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	SELL	$1.31 - $2.04 $203,443 - $316,812	-155,300 Reduced 63.62%	88,800 $142,000
Q1 2023 Aug 02, 2023	BUY	$1.45 - $2.95 $225,185 - $458,135	155,300 Added 174.89%	244,100 $371,000
Q4 2022 Jan 26, 2023	SELL	$2.02 - $3.25 $104,838 - $168,675	-51,900 Reduced 17.53%	244,100 $585,000
Q3 2022 Oct 27, 2022	SELL	$1.96 - $3.14 $116,228 - $186,202	-59,300 Reduced 16.69%	296,000 $606,000
Q2 2022 Jul 25, 2022	BUY	$1.3 - $2.64 $221,780 - $450,384	170,600 Added 92.37%	355,300 $689,000
Q4 2021 Jan 24, 2022	BUY	$2.92 - $5.74 $313,024 - $615,328	107,200 Added 138.32%	184,700 $594,000
Q2 2021 Jul 26, 2021	SELL	$2.56 - $5.49 $72,960 - $156,465	-28,500 Reduced 26.89%	77,500 $425,000
Q1 2021 Apr 23, 2021	SELL	$2.69 - $5.25 $41,426 - $80,850	-15,400 Reduced 12.69%	106,000 $288,000
Q4 2020 Jan 25, 2021	SELL	$3.17 - $4.49 $18,703 - $26,491	-5,900 Reduced 4.63%	121,400 $386,000
Q3 2020 Dec 14, 2020	SELL	$2.98 - $5.2 $38,144 - $66,560	-12,800 Reduced 9.14%	127,300 $509,000
Q2 2020 Jul 23, 2020	SELL	$2.29 - $4.24 $67,097 - $124,232	-29,300 Reduced 17.3%	140,100 $550,000
Q4 2019 Jan 24, 2020	SELL	$2.41 - $4.4 $69,890 - $127,600	-29,000 Reduced 14.62%	169,400 $689,000
Q2 2019 Jul 25, 2019	BUY	$2.53 - $3.04 $501,951 - $603,136	198,400 New	198,400 $595,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.